← Eichor
Study identifier: NCT07393880 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus

Condition: Tinnitus, Subjective · Tinnitus · Chronic Tinnitus  ·  Sponsor: University of Dublin, Trinity College

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study tests whether pairing non-invasive stimulation of the greater occipital nerve (NITESGON) with an attentionally demanding auditory frequency discrimination training task reduces tinnitus loudness and tinnitus-related distress. One hundred adults with chronic tonal tinnitus will be randomised to one of four groups in a 2×2 factorial design: real versus sham NITESGON and active versus passive listening during auditory stimulation. Participants complete eight sessions across four weeks, with outcomes assessed at baseline, end of treatment, 28 days post-treatment, and 6 months post-treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Sven Vanneste, PhD  ·  +353 87 470 2835.  ·  sven.vanneste@tcd.ie

Anusha Mohan, PhD  ·  anusha.mohan@tcd.ie

Always discuss trial participation with your own doctor first.

Locations (1)

Trinity College Institute of Neuroscience (TCIN)Dublin, Dublin, IrelandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07393880